Simplified Chinese
scroll down
05
2022-08
Recently, the inaugural “CBP” Employee Esports Tournament—sponsored by the Daxing District Federation of Trade Unions and the Biomedical Base Management Committee, and organized by the Biomedical Industry Base Federation of Trade Unions—kicked off. Following three weeks of online competition, the grand finals were held on the morning of August 4 at the Biomedical Base Science and Innovation Cultural Center. More than 300 employees from 62 teams representing various companies within the park enthusiastically took part, rallying for passion and glory, striving relentlessly for their dreams, and boldly scaling the heights of championship supremacy. “The enemy forces have 5 seconds to reach the battlefield,” an inspiring voice echoed throughout the venue, as all competitors remained fully focused, deploying a dazzling array of skills in turn, delivering textbook‑perfect…
28
2022-07
On July 28, 2022, the China Hepatitis Prevention and Control Foundation convened the “2022 Symposium on Eliminating the Public Health Burden of Viral Hepatitis” in Beijing. The symposium was attended by Wang Yu, Chairman of the China Hepatitis Prevention and Control Foundation, representatives from Kangtai Biological—the manufacturer of the hepatitis B vaccine—along with prominent experts and scholars from institutions such as the Institute of Public Health at Peking University and other organizations dedicated to hepatitis prevention and control. This symposium was held to implement the Outline of the “Healthy China 2030” Plan, support the achievement of the targets set forth in the “Healthy China Action (2019–2030),” and advance the national goal of eliminating the public health burden of hepatitis. It also reviewed the progress made over the past three decades in China…
21
2022-07
Kangtai Biological was honored as one of the “Top 10 Chinese Biopharmaceutical Companies of 2021.”
On July 12, the Expert Committee of the Top 100 Chinese Pharmaceutical Companies Ranking released the “2021 Series of Rankings for China’s Top 100 Pharmaceutical Enterprises.” Shenzhen Kangtai Biological Products Co., Ltd. was honored as one of the “Top 10 Chinese Biopharmaceutical Companies in 2021.” This year’s selection focused on the innovation-driven capabilities and professional marketing strength of pharmaceutical companies, evaluating them based on comprehensive R&D investment metrics and quantitative market demand data, thereby establishing significant authority and influence within the industry. Founded in 1992, Kangtai Biological has, over the past three decades, remained dedicated to the research, development, production, and sales of human vaccines, and has now grown into a leading domestic and internationally recognized enterprise.
12
2022-07
Conducting field visits and surveys to gain a clear understanding of the situation, soliciting enterprises’ needs to promote development—Shi Yinfeng, Deputy Secretary of the Daxing District Party Committee, paid a visit to Minhai for research and guidance. On the afternoon of July 6, 2022, Shi Yinfeng, accompanied by Ma Yanzhu from the District Industrial Promotion Center and Zhang Long, General Manager of the Biopharmaceutical Base Company, led a delegation to Minhai Bio for an inspection and guidance session. The company’s General Manager Zheng Haifa, Executive Deputy General Manager Liu Jiankai, Production Deputy General Manager Nie Xiaoqi, and other relevant leaders were present to receive and accompany the group. At the briefing, General Manager Zheng first extended a warm welcome on behalf of the company’s leadership to Secretary Shi and his delegation. He then briefed the officials on the company’s development journey and recent…
25
2022-06
To strengthen enterprises’ ability to prevent accident risks and ensure the safe management of hazardous chemicals, on June 24, Zhai Yang, a member of the Party Leadership Group and Deputy District Mayor of Daxing District, led a team to the company for a comprehensive safety inspection of hazardous chemical operations. Li Gang, Party Secretary and Director of the Daxing District Emergency Management Bureau; Zhang Long, General Manager of the Biomedical Base Management Committee; and Hu Wei, Section Chief of the Hazardous Chemicals Division of the Daxing District Emergency Management Bureau, also participated in the inspection. Company General Manager Zheng Haifa, along with Wu Chengyu, Zhang Yidi, and other company representatives, accompanied the team. The inspection focused on the safe storage, use, and management of hazardous chemicals. Following the inspection, Director Li Gang emphasized three key points: first, prioritize equipment reliability by conducting regular checks to ensure proper operation; second, intensify safety training and education for all personnel to enhance safety safeguards and emergency response capabilities; and third, closely monitor the adverse impacts of extreme weather conditions such as high temperatures and heavy rainfall, conduct proactive risk assessments, and implement effective preventive measures. Section Chief Hu Wei outlined specific requirements for safety management. Deputy District Mayor Zhai underscored the following priorities: first, raise awareness of hazardous chemical safety management and bolster accident‑prevention capabilities, fully implementing the directives from the Daxing District’s meeting on deploying the large‑scale safety inspection of hazardous‑chemical enterprises and refining all control measures; second, rigorously enforce the principal responsibility of enterprises for workplace safety, ensuring that top executives take charge, conducting thorough hazard identification and remediation without leaving any blind spots; and third, leverage this on-site visit to gain an in-depth understanding of each enterprise’s needs and challenges, promptly formulating targeted measures to help alleviate their difficulties. General Manager Zheng affirmed the company’s unwavering commitment to implementing all safety requirements and measures related to hazardous chemicals, strengthening corporate safety awareness, promoting a culture of safety, and eliminating potential risks. He added that, taking “Safety Production Month” as an opportunity, the company will strive to elevate its safety‑production efforts to a new level.
Contact Information
Customer Service Hotline
4001899806
Phone number
010-59613600
Official Website
Company Address
No. 35 Simiao Road and No. 25 Tianfu Street, Daxing Biomedical Industry Base, Zhongguancun Science Park, Daxing District, Beijing
WeChat Official Account
0
%